Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice

Cell Metabolism

Volumn 17, Issue 5, 2013, Pages 779-789

  Lin, Zhuofeng ^a   Tian, Haishan ^a   Lam, Karen S L ^b   Lin, Shaoqiang ^a   Hoo, Ruby C L ^b   Konishi, Morichika ^c   Itoh, Nobuyuki ^c   Wang, Yu ^b   Bornstein, Stefan R ^d   Xu, Aimin ^a,b   Li, Xiaokun ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c KYOTO UNIVERSITY   (Japan)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FIBROBLAST GROWTH FACTOR 21; GLUCOSE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID OXIDATION; FATTY LIVER; GLUCOSE HOMEOSTASIS; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; SKELETAL MUSCLE;

ADIPOCYTES; ADIPONECTIN; ANIMALS; ENERGY METABOLISM; FATTY ACIDS; FATTY LIVER; FIBROBLAST GROWTH FACTORS; GLUCOSE; HOMEOSTASIS; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OBESITY; OXIDATION-REDUCTION;

EID: 84877260638     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2013.04.005     Document Type: Article

References (50)

1. A.C. Adams, C. Yang, T. Coskun, C.C. Cheng, R. Gemeno, Y. Luo, and A. Kharitonenkov The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue Molecular Metabolism 2 2013 31 37
2. M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab. 5 2007 426 437
3. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat. Med. 7 2001 947 953
4. E.D. Berglund, C.Y. Li, H.A. Bina, S.E. Lynes, M.D. Michael, A.B. Shanafelt, A. Kharitonenkov, and D.H. Wasserman Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity Endocrinology 150 2009 4084 4093
5. J. Chang, Y. Li, Y. Huang, K.S. Lam, R.L. Hoo, W.T. Wong, K.K. Cheng, Y. Wang, P.M. Vanhoutte, and A. Xu Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway Diabetes 59 2010 2949 2959
6. M.D. Chau, J. Gao, Q. Yang, Z. Wu, and J. Gromada Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway Proc. Natl. Acad. Sci. USA 107 2010 12553 12558
7. C. Chen, B.M. Cheung, A.W. Tso, Y. Wang, L.S. Law, K.L. Ong, N.M. Wat, A. Xu, and K.S. Lam High plasma level of fibroblast growth factor 21 is an Independent predictor of type 2 diabetes: a 5.4-year population-based prospective study in Chinese subjects Diabetes Care 34 2011 2113 2115
8. W. Chen, R.L. Hoo, M. Konishi, N. Itoh, P.C. Lee, H.Y. Ye, K.S. Lam, and A. Xu Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes J. Biol. Chem. 286 2011 34559 34566
9. T. Coskun, H.A. Bina, M.A. Schneider, J.D. Dunbar, C.C. Hu, Y. Chen, D.E. Moller, and A. Kharitonenkov Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
10. J. Díaz-Delfín, E. Hondares, R. Iglesias, M. Giralt, C. Caelles, and F. Villarroya TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway Endocrinology 153 2012 4238 4245
11. X. Ding, J. Boney-Montoya, B.M. Owen, A.L. Bookout, K.C. Coate, D.J. Mangelsdorf, and S.A. Kliewer βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism Cell Metab. 16 2012 387 393
12. P.A. Dutchak, T. Katafuchi, A.L. Bookout, J.H. Choi, R.T. Yu, D.J. Mangelsdorf, and S.A. Kliewer Fibroblast growth factor-21 regulates PPARγ activity and the antidiabetic actions of thiazolidinediones Cell 148 2012 556 567
13. M. Fasshauer, S. Kralisch, M. Klier, U. Lossner, M. Bluher, J. Klein, and R. Paschke Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes Biochem. Biophys. Res. Commun. 301 2003 1045 1050
14. F.M. Fisher, P.C. Chui, P.J. Antonellis, H.A. Bina, A. Kharitonenkov, J.S. Flier, and E. Maratos-Flier Obesity is a fibroblast growth factor 21 (FGF21)-resistant state Diabetes 59 2010 2781 2789
15. F.M. Fisher, J.L. Estall, A.C. Adams, P.J. Antonellis, H.A. Bina, J.S. Flier, A. Kharitonenkov, B.M. Spiegelman, and E. Maratos-Flier Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo Endocrinology 152 2011 2996 3004
16. X. Ge, C. Chen, X. Hui, Y. Wang, K.S. Lam, and A. Xu Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes J. Biol. Chem. 286 2011 34533 34541
17. E. Hondares, R. Iglesias, A. Giralt, F.J. Gonzalez, M. Giralt, T. Mampel, and F. Villarroya Thermogenic activation induces FGF21 expression and release in brown adipose tissue J. Biol. Chem. 286 2011 12983 12990
18. Y. Hotta, H. Nakamura, M. Konishi, Y. Murata, H. Takagi, S. Matsumura, K. Inoue, T. Fushiki, and N. Itoh Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver Endocrinology 150 2009 4625 4633
19. T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, and V. Esser Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab. 5 2007 415 425
20. M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, M. Makishima, and I. Shimomura Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 2003 1655 1663
21. T. Kadowaki, T. Yamauchi, N. Kubota, K. Hara, K. Ueki, and K. Tobe Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome J. Clin. Invest. 116 2006 1784 1792
22. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, and R.A. Owens FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
23. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
24. A. Kharitonenkov, J.D. Dunbar, H.A. Bina, S. Bright, J.S. Moyers, C. Zhang, L. Ding, R. Micanovic, S.F. Mehrbod, and M.D. Knierman FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J. Cell. Physiol. 215 2008 1 7
25. J.Y. Kim, E. van de Wall, M. Laplante, A. Azzara, M.E. Trujillo, S.M. Hofmann, T. Schraw, J.L. Durand, H. Li, and G. Li Obesity-associated improvements in metabolic profile through expansion of adipose tissue J. Clin. Invest. 117 2007 2621 2637
26. N. Kubota, Y. Terauchi, T. Kubota, H. Kumagai, S. Itoh, H. Satoh, W. Yano, H. Ogata, K. Tokuyama, and I. Takamoto Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways J. Biol. Chem. 281 2006 8748 8755
27. H. Li, Y. Xiao, H. Liu, X.Y. Chen, X.Y. Li, W.L. Tang, S.P. Liu, A.M. Xu, and Z.G. Zhou Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study Chin. Med. J. (Engl.) 124 2011 3607 3612
28. H. Li, Z. Gao, J. Zhang, X. Ye, A. Xu, J. Ye, and W. Jia Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3 Diabetes 61 2012 797 806
29. R.S. Lindsay, T. Funahashi, R.L. Hanson, Y. Matsuzawa, S. Tanaka, P.A. Tataranni, W.C. Knowler, and J. Krakoff Adiponectin and development of type 2 diabetes in the Pima Indian population Lancet 360 2002 57 58
30. M. Liu, and F. Liu Transcriptional and post-translational regulation of adiponectin Biochem. J. 425 2010 41 52
31. M. Liu, L. Zhou, A. Xu, K.S. Lam, M.D. Wetzel, R. Xiang, J. Zhang, X. Xin, L.Q. Dong, and F. Liu A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization Proc. Natl. Acad. Sci. USA 105 2008 18302 18307
32. K. Ma, A. Cabrero, P.K. Saha, H. Kojima, L. Li, B.H. Chang, A. Paul, and L. Chan Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin J. Biol. Chem. 277 2002 34658 34661
33. A.R. Nawrocki, M.W. Rajala, E. Tomas, U.B. Pajvani, A.K. Saha, M.E. Trumbauer, Z. Pang, A.S. Chen, N.B. Ruderman, and H. Chen Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists J. Biol. Chem. 281 2006 2654 2660
34. M.J. Potthoff, T. Inagaki, S. Satapati, X. Ding, T. He, R. Goetz, M. Mohammadi, B.N. Finck, D.J. Mangelsdorf, S.A. Kliewer, and S.C. Burgess FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc. Natl. Acad. Sci. USA 106 2009 10853 10858
35. M.J. Potthoff, S.A. Kliewer, and D.J. Mangelsdorf Endocrine fibroblast growth factors 15/19 and 21: from feast to famine Genes Dev. 26 2012 312 324
36. M. Suzuki, Y. Uehara, K. Motomura-Matsuzaka, J. Oki, Y. Koyama, M. Kimura, M. Asada, A. Komi-Kuramochi, S. Oka, and T. Imamura betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Mol. Endocrinol. 22 2008 1006 1014
37. M.M. Véniant, C. Hale, J. Helmering, M.M. Chen, S. Stanislaus, J. Busby, S. Vonderfecht, J. Xu, and D.J. Lloyd FGF21 promotes metabolic homeostasis via white adipose and leptin in mice PLoS ONE 7 2012 e40164
38. Y. Wang, K.S. Lam, L. Chan, K.W. Chan, J.B. Lam, M.C. Lam, R.C. Hoo, W.W. Mak, G.J. Cooper, and A. Xu Post-translational modifications of the four conserved lysine residues within the collagenous domain of adiponectin are required for the formation of its high molecular weight oligomeric complex J. Biol. Chem. 281 2006 16391 16400
39. Z.V. Wang, T.D. Schraw, J.Y. Kim, T. Khan, M.W. Rajala, A. Follenzi, and P.E. Scherer Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention Mol. Cell. Biol. 27 2007 3716 3731
40. Y. Wang, K.S. Lam, M.H. Yau, and A. Xu Post-translational modifications of adiponectin: mechanisms and functional implications Biochem. J. 409 2008 623 633
41. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, R.E. Pratley, and P.A. Tataranni Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia J. Clin. Endocrinol. Metab. 86 2001 1930 1935
42. A. Xu, Y. Wang, H. Keshaw, L.Y. Xu, K.S. Lam, and G.J. Cooper The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice J. Clin. Invest. 112 2003 91 100
43. A. Xu, K.W. Chan, R.L. Hoo, Y. Wang, K.C. Tan, J. Zhang, B. Chen, M.C. Lam, C. Tse, G.J. Cooper, and K.S. Lam Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes J. Biol. Chem. 280 2005 18073 18080
44. A. Xu, H. Wang, R.L. Hoo, G. Sweeney, P.M. Vanhoutte, Y. Wang, D. Wu, W. Chu, G. Qin, and K.S. Lam Selective elevation of adiponectin production by the natural compounds derived from a medicinal herb alleviates insulin resistance and glucose intolerance in obese mice Endocrinology 150 2009 625 633
45. J. Xu, D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y.S. Li, and R.A. Lindberg Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
46. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, K. Hara, Y. Mori, T. Ide, K. Murakami, and N. Tsuboyama-Kasaoka The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat. Med. 7 2001 941 946
47. C. Yang, C. Jin, X. Li, F. Wang, W.L. McKeehan, and Y. Luo Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB PLoS ONE 7 2012 e33870
48. H. Yu, F. Xia, K.S. Lam, Y. Wang, Y. Bao, J. Zhang, Y. Gu, P. Zhou, J. Lu, W. Jia, and A. Xu Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans Clin. Chem. 57 2011 691 700
49. X. Zhang, D.C. Yeung, M. Karpisek, D. Stejskal, Z.G. Zhou, F. Liu, R.L. Wong, W.S. Chow, A.W. Tso, K.S. Lam, and A. Xu Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 2008 1246 1253
50. M. Zhou, A. Xu, P.K. Tam, K.S. Lam, L. Chan, R.L. Hoo, J. Liu, K.H. Chow, and Y. Wang Mitochondrial dysfunction contributes to the increased vulnerabilities of adiponectin knockout mice to liver injury Hepatology 48 2008 1087 1096